5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.29▼ | 2.30▼ | 2.31▼ | 2.33▼ | 2.39▼ |
MA10 | 2.29▼ | 2.31▼ | 2.32▼ | 2.49▼ | 2.20▲ |
MA20 | 2.31▼ | 2.32▼ | 2.39▼ | 2.44▼ | 2.10▲ |
MA50 | 2.32▼ | 2.37▼ | 2.43▼ | 2.18▲ | 2.29▼ |
MA100 | 2.40▼ | 2.47▼ | 2.56▼ | 2.10▲ | N/A |
MA200 | 2.38▼ | 2.56▼ | 2.34▼ | 2.30▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.000▼ | -0.005▼ | -0.054▼ | 0.056▲ |
RSI | 39.318▼ | 40.821▼ | 40.664▼ | 46.152▼ | 51.543▲ |
STOCH | 22.222 | 48.071 | 44.819 | 18.988▼ | 56.780 |
WILL %R | -100.000▼ | -62.069 | -80.357▼ | -82.266▼ | -56.429 |
CCI | -147.022▼ | -47.141 | -85.191 | -124.154▼ | 61.210 |
Thursday, February 25, 2021 04:49 PM
AIM ImmunoTech announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself ...
|
Thursday, February 25, 2021 02:27 AM
AIM ImmunoTech Inc's (NYSE: AIM) subsidiary, NV Hemispherx Biopharma Europe, has received formal notification from the European Commission for Orphan Medicinal Product Application for Ampligen as a ...
|
Wednesday, February 24, 2021 09:27 AM
AIM ImmunoTech Inc. (NYSE:AIM) is an immuno-pharma company headquartered in Ocala, Florida which is focused on the research and development of therapeutics to treat multiple types of cancers, as well ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/02/21 | 2.29 | 2.37 | 2.21 | 2.26 | 1,178,279 |
25/02/21 | 2.47 | 2.51 | 2.31 | 2.35 | 1,936,633 |
24/02/21 | 2.54 | 2.70 | 2.33 | 2.35 | 7,117,526 |
23/02/21 | 2.28 | 2.35 | 2.0897 | 2.26 | 2,611,596 |
22/02/21 | 2.46 | 2.51 | 2.42 | 2.44 | 1,211,232 |
19/02/21 | 2.51 | 2.5499 | 2.4711 | 2.4711 | 1,131,596 |
18/02/21 | 2.60 | 2.6062 | 2.46 | 2.49 | 1,680,111 |
17/02/21 | 2.71 | 2.72 | 2.5809 | 2.69 | 1,753,370 |
16/02/21 | 2.90 | 2.93 | 2.76 | 2.78 | 2,364,616 |
12/02/21 | 2.69 | 2.84 | 2.64 | 2.76 | 2,320,276 |
|
|
||||
|
|
||||
|
|